Unknown

Dataset Information

Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases.


ABSTRACT: Background Asbestos exposure is associated with increased risk of several diseases, including malignant mesothelioma (MM). Cell surface glycoprotein mesothelin is overexpressed in MM and serum soluble mesothelin-related peptides (SMRP) were already proposed as a diagnostic or prognostic biomarker in MM. However, interindividual variability in serum SMRP levels limits the clinical usefulness. Our primary objective was to investigate the influence of MSLN rs1057147 on serum SMRP levels in asbestos-exposed subjects and patients with asbestos-related diseases as well as on survival in MM. Subjects and methods Among 782 asbestos-exposed subjects and patients with asbestos-related diseases, 154 had MM. Serum SMRP levels were determined using sandwich enzyme-linked immunosorbent assay. All subjec

SUBMITTER: Goricar K 

PROVIDER: S-EPMC7087423 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature